The European landscape presents a unique evolution in the understanding of psychedelics. Long stigmatized, these substances are now gain traction for their potential therapeutic applications. From Switzerland, where studies are being conducted, to the Italy, where open conversations is expanding, Europe is at the forefront in this resurgence of cop